CD276 and Familial prostate cancer: Meanwhile, CD276 is overexpressed in many malignant tumors, and this overexpression accelerate the metastasis of cancer cells in vitro, which is often linked to poor clinical prognosis.32,34 These lines of evidence allowed us to discern the effect of miR-187 targeting CD276 on the biological function of prostate cancer cells.